tradingkey.logo

Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

ReutersMar 5, 2025 10:25 PM

- Aquestive Therapeutics Inc AQST.O:

  • AQUESTIVE THERAPEUTICS, INC. Q4 ADJUSTED EBITDA USD -11.029 MILLION

  • AQUESTIVE THERAPEUTICS, INC. Q4 PRETAX PROFIT USD -17.069 MILLION VERSUS. IBES ESTIMATE USD -12.7 MILLION

  • AQUESTIVE THERAPEUTICS, INC. Q4 INCOME FROM OPERATIONS USD -13.579 MILLION VERSUS. IBES ESTIMATE USD -9.57 MILLION

  • AQUESTIVE THERAPEUTICS, INC. Q4 NET INCOME USD -17.055 MILLION VERSUS. IBES ESTIMATE USD -12.8 MILLION

  • AQUESTIVE THERAPEUTICS, INC. Q4 REVENUE USD 11.867 MILLION VERSUS. IBES ESTIMATE USD 13.1 MILLION

  • : QTRLY LOSS PER SHARE $0.19

  • OUTLOOK FY TOTAL REVENUE $47MLN TO $56 MILLION

  • FY2025 REVENUE VIEW $53.0 MILLION -- LSEG IBES DATA

Further company coverage: AQST.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI